Target Name: NPY
NCBI ID: G4852
Review Report on NPY Target / Biomarker Content of Review Report on NPY Target / Biomarker
NPY
Other Name(s): neuropeptide Y | Neuropeptide Y | Neuropeptide tyrosine | PYY4 | CPON | NPY_HUMAN | Neuropeptide Y precursor | Pro-neuropeptide Y | C-flanking peptide of NPY | prepro-neuropeptide Y

Understanding The Role of Neuropeptide Y in Various Biological Processes

Neuropeptide Y (NPY) is a small protein that is expressed in various tissues throughout the body, including the brain, where it plays a crucial role in the regulation of appetite and metabolism. NPY is a key mediator of the effects of the neurotransmitter serotonin on these processes, and its levels have been implicated in a number of neuropsychiatric and neurological disorders.

The research on NPY has been ongoing for several decades, and in recent years, significant progress has been made in the understanding of its role in various biological processes. One of the most significant findings is the role of NPY in the regulation of appetite, particularly in the treatment of obesity.

Obesity is a growing health problem that is associated with a number of negative consequences, including increased risk for cardiovascular disease, diabetes, and certain cancers. The ability of NPY to regulate appetite has made it an attractive drug target for researchers, and several studies have suggested that inhibiting NPY activity may be a effective way to treat obesity.

One of the main mechanisms by which NPY regulates appetite is through its effects on the release of food intake from the stomach. Studies have shown that when NPY is administered to rats or mice, it decreases the amount of food they consume, and this effect is mediated by the neurotransmitter dopamine.

In addition to its role in appetite regulation, NPY has also been shown to play a role in the regulation of other physiological processes, including sleep, mood, and pain. For example, studies have shown that NPY is involved in the regulation of the sleep-wake cycle and that its levels are decreased in individuals with insomnia.

NPY has also been implicated in the development and progression of a number of neurological disorders, including Parkinson's disease, Alzheimer's disease, and depression. The exact mechanisms by which NPY is involved in these disorders is not well understood, but it is thought to be involved in the disruption of normal cellular processes that occur in these conditions.

Despite the significant progress that has been made in the research on NPY, much work remains to be done in order to fully understand its role in various biological processes. In addition, the development of new treatments for NPY-related disorders remains a major focus of research, and the identification of new potential drug targets is an important step in this process.

In conclusion, NPY is a neuropeptide that has been shown to play a crucial role in various biological processes, including appetite regulation and the regulation of sleep, mood, and pain. The research on NPY has made significant progress in recent years, and the identification of new potential drug targets is an important step in the development of new treatments for NPY-related disorders. Further research is needed to fully understand the role of NPY in various biological processes and to develop new treatments for these disorders.

Protein Name: Neuropeptide Y

Functions: NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone

The "NPY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3